Tom Cotton @SenTomCotton
Johnson & Johnson filed for Emergency Use Authorization for its vaccine candidate on February 4. The FDA has had access to the company’s data for months, yet the FDA’s advisory committee is slow rolling this process and waiting three weeks to even discuss final approval. — PolitiTweet.org